Company Profiles

driven by the PitchBook Platform

Accuitis

2011 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Angel LATEST DEAL TYPE
$1.75M LATEST DEAL AMOUNT
$1.75M TOTAL AMOUNT RAISED
Description

Developer and marketer of pharmaceuticals for dermatological diseases. The company provides drugs for the treatment of rosacea, which is a dermatological ophthalmic condition.

Website:
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
4920 Pond Ridge Lane
Cumming, GA 30041
United States

+1 (678) 812-1492
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Accuitis’s full profile, request a free trial.

Accuitis Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 05-Sep-2017 $1.75M $1.75M Completed Startup
1. Grant Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Accuitis Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Bio/Med Investor Network Angel Group Minority 000 0000 000000 0
Georgia Research Alliance Government 000 0000 000000 0
Robert Jason Thomas Angel (individual) Minority 000 0000 000000 0

Accuitis Executive Team (5)

Name Title Board
Seat
Contact
Info
Richard Coulon Chief Executive Officer, Co-Founder and Board Member
Michael Shippel Chief Financial Officer & Board Member
Jack Arbiser Ph.D Co-Founder & Chief Innovation Officer
Tom Rowe Co-Founder
Mark Jackson MD Chief Medical Officer

Accuitis Board Members (4)

Name Representing Role Since Contact
Info
Geoffrey Meacham Bio/Med Investor Network Board Member 000 0000
Michael Shippel Accuitis Chief Financial Officer & Board Member 000 0000
Robert Thomas Ph.D Accuitis Board Member 000 0000
Stephen Martin JD Accuitis Board Member 000 0000